ChromaDex Corporation (CDXC) Social Stream
CHROMADEX CORP (CDXC) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering CHROMADEX CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-02-10 | 4 | $17 | $12 | $14.25 | $1.46 | 876.03% |
| 2022-03-08 | 5 | $17 | $7 | $12.8 | $1.46 | 776.71% |
| 2022-03-10 | 5 | $17 | $7 | $10.8 | $1.46 | 639.73% |
| 2022-04-18 | 5 | $17 | $7 | $10 | $1.46 | 584.93% |
| 2022-05-13 | 5 | $17 | $6 | $9.6 | $1.46 | 557.53% |
| 2022-05-17 | 5 | $8.6 | $6 | $7.32 | $1.46 | 401.37% |
| 2022-06-07 | 4 | $8.6 | $5.75 | $6.87 | $1.46 | 370.55% |
| 2022-08-11 | 5 | $7.5 | $2.4 | $5.63 | $1.46 | 285.62% |
| 2022-10-13 | 5 | $7.5 | $2.4 | $4.912 | $1.46 | 236.44% |
| 2023-03-09 | 5 | $7.5 | $2.1 | $4.837 | $1.46 | 231.3% |
| 2023-03-13 | 5 | $7.5 | $2 | $4.687 | $1.46 | 221.03% |
| 2023-08-11 | 4 | $6.6 | $2 | $4.462 | $1.46 | 205.62% |
| 2023-11-09 | 4 | $6 | $2 | $4.312 | $1.46 | 195.34% |
The Trend in the Analyst Price Target
Over the past 33 months, CDXC's average price target has gone down $3.59.
Over the past 40 weeks, CDXC's average upside potential has been 185.61%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-01 | 5 | 7.5 | 2.1 | 4.837 | 2.06 | 134.81% |
| 2023-03-13 | 4 | 7.5 | 2.0 | 4.687 | 1.60 | 192.94% |
| 2023-05-11 | 4 | 6.6 | 2.0 | 4.462 | 1.51 | 195.5% |
| 2023-08-11 | 4 | 6.6 | 2.0 | 4.462 | 1.59 | 180.63% |
| 2023-11-09 | 4 | 6.0 | 2.0 | 4.312 | 1.42 | 203.66% |
CDXC Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 3 | 0 | 1 | 0 | 0 | 4 |
The Trend in the Broker Recommendations
CDXC's average broker recommendation rating worsened by 0.5 over the prior 40 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how CHROMADEX CORP fares relative to all US stocks, note that its average analyst price target is greater than 140.12% of that group.
- In the context of all US stocks, CHROMADEX CORP's upside potential (average analyst target price relative to current price) is greater than 1652.88% of them.
- In the context of all US stocks, CHROMADEX CORP's number of analysts covering the stock is higher than 330.7% of them.
- In terms of how CHROMADEX CORP fares relative to Healthcare stocks, note that its variance in analysts' estimates is lower than -1015.22% of that group.
In the Pharmaceutical Products industry, AWH, TRIB, and THTX are the three stocks most similar to CHROMADEX CORP regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding CDXC using the data that counts. Try POWR Ratings for free.